Status:

RECRUITING

To Evaluate the Delivery Timing Safety and Efficacy of AntiTachycardia Pacing (BIO|ATP)

Lead Sponsor:

Biotronik SE & Co. KG

Collaborating Sponsors:

Biotronik Japan, Inc.

Conditions:

Implantable Cardioverter Defibrillator(ICD)

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

To compare Treatment Group (settings of Early Multiple ATP) and Control Group (settings of extended detection time for the conventional ATP) in Japanese patients, and confirm their safety and efficacy

Detailed Description

The enrolled patients are randomized to Treatment Group with setting to provide Antitachycardiac Pacing (ATP) multiple times at an early timing or Control Group with Long Detection setting for the con...

Eligibility Criteria

Inclusion

  • Patient has an indication for ICD according to the The Japanese Circulation Society (JCS )/ Japanese Heart Rhythm Society (JHRS) 2021 Guideline Focused Update on Non-Pharmacotherapy of Cardiac Arrhythmias
  • Patient is either planned for de novo ICD implantation or is already implanted with an investigational ICD for 10 days or less.
  • Patient can be treated with ATP therapy for both VT and VF zone
  • Patient is willing and able to use the CardioMessenger and accepts the Home Monitoring concept
  • Patient is willing to visit the hospital in accordance with physician's instruction
  • Patient is able to understand the nature of the study and to provide written informed consent

Exclusion

  • Patient planned for implantation with or already implanted with Cardiac Resynchronization Therapy Defibrillator (CRT-D) device
  • A patient who is confirmed to have received ICD therapy
  • A patient who is diagnosed as Idiopathic VF (e.g. Brugada syndrome, Long QT Syndrome, other IVF)
  • Age \< 18 years
  • A patient who has impaired mental status
  • Life expectancy less than 18 months
  • Participation in another interventional clinical investigation
  • Pregnant or breastfeeding

Key Trial Info

Start Date :

May 15 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 31 2028

Estimated Enrollment :

398 Patients enrolled

Trial Details

Trial ID

NCT05426785

Start Date

May 15 2023

End Date

May 31 2028

Last Update

February 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kokura Memorial Hospital

Kitakyushu, Fukuoka, Japan, 8028555